178 related articles for article (PubMed ID: 11996173)
1. Cytopathology of pleural mesotheliomas.
Nguyen GK
Am J Clin Pathol; 2000 Nov; 114 Suppl():S68-81. PubMed ID: 11996173
[TBL] [Abstract][Full Text] [Related]
2. The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma.
Rakha EA; Patil S; Abdulla K; Abdulkader M; Chaudry Z; Soomro IN
Diagn Cytopathol; 2010 Dec; 38(12):874-9. PubMed ID: 20049969
[TBL] [Abstract][Full Text] [Related]
3. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
4. Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma.
Sherman ME; Mark EJ
Arch Pathol Lab Med; 1990 Aug; 114(8):845-51. PubMed ID: 2375659
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical differential diagnosis of pleural effusions, with emphasis on malignant mesothelioma.
Wick MR; Moran CA; Mills SE; Suster S
Curr Opin Pulm Med; 2001 Jul; 7(4):187-92. PubMed ID: 11470972
[TBL] [Abstract][Full Text] [Related]
6. Transudates in malignancy: still a role for pleural fluid.
Gonlugur TE; Gonlugur U
Ann Acad Med Singap; 2008 Sep; 37(9):760-3. PubMed ID: 18989492
[TBL] [Abstract][Full Text] [Related]
7. Cytologic presentation of malignant mesothelioma in pleural effusions.
Pedio G; Landolt-Weber U
Exp Cell Biol; 1988; 56(4):211-6. PubMed ID: 3203820
[TBL] [Abstract][Full Text] [Related]
8. The diagnosis of malignant mesothelioma in effusion cytology: a reappraisal and results of a multi-institution survey.
Paintal A; Raparia K; Zakowski MF; Nayar R
Cancer Cytopathol; 2013 Dec; 121(12):703-7. PubMed ID: 24039177
[TBL] [Abstract][Full Text] [Related]
9. Malignant biphasic pleural mesothelioma metastatic to the liver diagnosed by fine-needle aspiration.
Cimbaluk D; Kasuganti D; Kluskens L; Reddy V; Gattuso P
Diagn Cytopathol; 2006 Jan; 34(1):33-6. PubMed ID: 16355399
[TBL] [Abstract][Full Text] [Related]
10. The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: an institutional experience.
Rossi ED; Bizzarro T; Schmitt F; Longatto-Filho A
Cancer Cytopathol; 2015 Apr; 123(4):258-66. PubMed ID: 25641902
[TBL] [Abstract][Full Text] [Related]
11. The cytologic diagnosis of mesothelioma.
Ehya H
Semin Diagn Pathol; 1986 Aug; 3(3):196-203. PubMed ID: 3616223
[TBL] [Abstract][Full Text] [Related]
12. Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology.
Jo VY; Cibas ES; Pinkus GS
Cancer Cytopathol; 2014 Apr; 122(4):299-306. PubMed ID: 24421209
[TBL] [Abstract][Full Text] [Related]
13. Effusion cytology of pleural mesothelioma, epithelial type, with extreme cytoplasmic vacuolization.
Akin MR; Nguyen GK
Acta Cytol; 2004; 48(3):469-71. PubMed ID: 15192978
[No Abstract] [Full Text] [Related]
14. Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology.
Matsumoto S; Nabeshima K; Kamei T; Hiroshima K; Kawahara K; Hata S; Marukawa K; Matsuno Y; Taguchi K; Tsujimura T
Cancer Cytopathol; 2013 Aug; 121(8):415-22. PubMed ID: 23450849
[TBL] [Abstract][Full Text] [Related]
15. Aspiration biopsy cytology of mesothelioma.
Tao LC
Diagn Cytopathol; 1989; 5(1):14-21. PubMed ID: 2656144
[TBL] [Abstract][Full Text] [Related]
16. An Updated Contextual Approach to Mesothelial Proliferations in Pleural Effusion Cytology Leveraging Morphology, Ancillary Studies, and Novel Biomarkers.
Miller LJ; Holmes IM; Lew M
Arch Pathol Lab Med; 2024 Apr; 148(4):409-418. PubMed ID: 37622452
[TBL] [Abstract][Full Text] [Related]
17. Immunoperoxidase staining of malignant cells in pleural effusions.
Pastormerlo M
Pathologica; 1990; 82(1080):421-5. PubMed ID: 2284143
[TBL] [Abstract][Full Text] [Related]
18. Metastatic proximal epithelioid sarcoma in pleural effusion: cytopathologic findings and differential diagnosis.
Guan H; Haque F; Ali SZ
Diagn Cytopathol; 2013 Jun; 41(6):542-5. PubMed ID: 21953993
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the value of fibronectin as a tumour marker in malignant pleural mesothelioma.
Emri S; Ustündağ Y; Budak T; Karakoca Y; Ozdemir O
Monaldi Arch Chest Dis; 1997 Aug; 52(4):335-8. PubMed ID: 9401361
[TBL] [Abstract][Full Text] [Related]
20. The cytopathology of mesothelioma.
Tao LC
Acta Cytol; 1979; 23(3):209-13. PubMed ID: 294056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
